Development of this evidence summary

This evidence summary was developed for NICE by Bazian Ltd. The interim process statement sets out the process NICE uses to select topics for the evidence summaries for unlicensed/off-label medicines and how the summaries are developed, quality assured and approved for publication.

Project team

Bazian Ltd

Medicines Prescribing Centre, NICE

Peer reviewers and contributors

Emma Chambers, Public Involvement Programme, NICE

Satkartar Jandu, Merck Serono (UK)

Expert advisers

Dr Michael Costello, Senior Lecturer University of New South Wales, Sydney, Australia

Declarations of interest

No relevant interests declared.